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Abstract
Background: Platelet-derived growth factor A (PDGF-A) signals solely through PDGF-Rα, and is required for
fibroblast proliferation and transdifferentiation (fibroblast to myofibroblast conversion) during alveolar
development, because pdgfa-null mice lack both myofibroblasts and alveoli. However, these PDGF-A-mediated
mechanisms remain incompletely defined. At postnatal days 4 and 12 (P4 and P12), using mouse lung fibroblasts,
we examined (a) how PDGF-Rα correlates with ki67 (proliferation marker) or alpha-smooth muscle actin (αSMA,
myofibroblast marker) expression, and (b) whether PDGF-A directly affects αSMA or modifies stimulation by
transforming growth factor beta (TGFβ).
Methods:  Using flow cytometry we examined PDGF-Rα,  αSMA and Ki67 in mice which express green
fluorescent protein (GFP) as a marker for PDGF-Rα expression. Using real-time RT-PCR we quantified αSMA
mRNA in cultured Mlg neonatal mouse lung fibroblasts after treatment with PDGF-A, and/or TGFβ.
Results: The intensity of GFP-fluorescence enabled us to distinguish three groups of fibroblasts which exhibited
absent, lower, or higher levels of PDGF-Rα. At P4, more of the higher than lower PDGF-Rα + fibroblasts
contained Ki67 (Ki67+), and Ki67+ fibroblasts predominated in the αSMA + but not the αSMA- population. By
P12, Ki67+ fibroblasts comprised a minority in both the PDGF-Rα + and αSMA+ populations. At P4, most Ki67+
fibroblasts were PDGF-Rα + and αSMA- whereas at P12, most Ki67+ fibroblasts were PDGF-Rα- and αSMA-.
More of the PDGF-Rα + than - fibroblasts contained αSMA at both P4 and P12. In the lung, proximate αSMA was
more abundant around nuclei in cells expressing high than low levels of PDGF-Rα at both P4 and P12. Nuclear
SMAD 2/3 declined from P4 to P12 in PDGF-Rα-, but not in PDGF-Rα + cells. In Mlg fibroblasts, αSMA mRNA
increased after exposure to TGFβ, but declined after treatment with PDGF-A.
Conclusion:  During both septal eruption (P4) and elongation (P12), alveolar PDGF-Rα may enhance the
propensity of fibroblasts to transdifferentiate rather than directly stimulate αSMA, which preferentially localizes
to non-proliferating fibroblasts. In accordance, PDGF-Rα more dominantly influences fibroblast proliferation at
P4 than at P12. In the lung, TGFβ may overshadow the antagonistic effects of PDGF-A/PDGF-Rα signaling,
enhancing αSMA-abundance in PDGF-Rα-expressing fibroblasts.
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Background
Fibroblast proliferation and transdifferentiation (fibrob-
last to myofibroblast conversion) are key cellular func-
tions required for both normal alveolar development and
the progression of fibrotic pulmonary diseases. Whereas
many studies have focused on disease states, similar
mechanisms may account for both normal lung develop-
ment and remodelling after lung injury. Increased knowl-
edge of the links between these processes could introduce
more effective treatment strategies for terminal diseases
such as intrapulmonary fibrosis and chronic obstructive
pulmonary disease [1-3].
Alveolar septal formation involves coordinated expansion
of epithelial and mesenchymal cells and establishment of
a specialized epithelial-endothelial interface that permits
efficient gas exchange. The attenuated alveolar-capillary
basement membrane is interrupted at the thickened por-
tions of septum, which reside primarily at the base and at
the alveolar entry rings. Differentiated mesenchymal cells
such as the myofibroblasts, reside in these regions and
deposit extracellular collagen and elastic fibers that sup-
port the delicate intervening alveolar-capillary interface.
Myofibroblasts have been identified in the developing
pulmonary alveolar interstitium of a variety of species,
including rats [4], mice [5], sheep [6] and humans [7].
These specialized fibroblasts display smooth muscle cell-
like features, such as alpha-smooth muscle actin (αSMA)
expression [8,9].
The platelet-derived growth factor (PDGF) family, consist-
ing of the ligands A, B, C and D and the receptor tyrosine
kinases PDGF-Rα and β, regulate the proliferation, migra-
tion and differentiation of mesenchymal cells during
embryonic and postnatal development [10]. All four lig-
ands form dimers; whereas A and B can both homo- and
heterodimerize (AA, AB or BB), C and D exist solely as
homodimers (CC and DD). PDGF A signals solely via
PDGF-Rα, B and C via both PDGF-Rα and β, and D solely
via PDGF-Rβ. PDGFs A, B and C are expressed in the
developing mouse lung[11,12], but mice that are null for
the pdgf-a gene[13,14] display reduced numbers of PDGF-
Rα-expressing cells, lack myofibroblasts and elastin
deposits, and fail to develop alveoli. A role for PDGFs B
and C in alveolar septal formation and myofibroblast
development has not been identified, as both pdgfs-b and
-c null mice die in utero [15,16]. Therefore, the behavior of
PDGF-Rα-expressing mesenchymal cells may necessarily,
but not exclusively reflect the actions of PDGF-A.
Whereas it is well known that fibroblasts actively prolifer-
ate and deposit alveolar septal ECM [17], and that PDGF-
A/PDGF-Rα signaling is required for myofibroblast differ-
entiation [13,14], it remains unclear how PDGF-Rα
expression influences the timing of fibroblast prolifera-
tion and differentiation. Stimulatory and inhibitory sig-
nals normally confine myofibroblasts to the period of
pulmonary alveolarization and myofibroblasts are rarely
observed in the adult lung [18]. Understanding more
about these normal regulatory signals is important,
because myofibroblasts reappear in injured and inflamed
lung tissue, and contribute to the progression of fibrosis
which leads to scarring and eventual loss of lung function
[19].
Using green fluorescent protein (GFP) as an in vivo marker
for pulmonary PDGF-Rα expression, we have demon-
strated that fibroblasts actively expressing the PDGF-Rα
gene are more likely to contain αSMA (characteristic of
myofibroblasts) than their non-expressing counterparts
[20]. We have now investigated the relationships between
proliferation (using ki67 as a marker for proliferation)
and  αSMA gene expression in individual PDGF-Rα-
expressing + and non-expressing - lung fibroblasts.
Because PDGF-B antagonizes αSMA gene expression in
smooth muscle cells [21], we hypothesized that PDGF-
Rα-expressing lung fibroblasts differ from non-expressing
lung fibroblasts in their response to transforming growth
factor beta (TGFβ). TGFβ1 is well characterized as a medi-
ator of fibroblast to myofibroblast conversion [22-24]
and is important for alveolar development [25-27]. There-
fore using cultured mouse lung fibroblasts, we have exam-
ined potential direct effects of PDGF-A on αSMA. We have
also investigated whether the nuclear abundance of the
TGFβ signalling complex, SMAD 2/3 [28,29], differs in
PDGF-Rα expressing and non-expressing lung fibroblasts.
Methods
Reagents
Collagenase type I (288 U/mg), trypsin (8500 U/mg),
DNAse I (2080 KU/mg) and calcium chloride were pur-
chased from Sigma Aldrich (St Louis, MO). Monoclonal
rat anti-ki67 primary antibody was purchased from
DAKO North America, Inc. (Carpenteria, CA). Superscipt
II reverse transcriptase, dNTPs, Quant IT™ Oligreen R
ssDNA assay kit, Rat IgG2a isotype control, popo 3 iodide
dimeric cyanine nucleic acid stain (C4H58I4N6O2), and
Alexa Fluor 647-goat anti-rat and -goat anti-rabbit second-
ary IgGs were purchased from Invitrogen (Carlsbad, CA).
Phycoerythrin (PE) - anti-human monoclonal α-smooth
muscle actin antibody, Mouse IgG2a PE isotype control,
recombinant human PDGF-AA (221-AA) and porcine
TGFβ1 (101-B1) were purchased from R & D Systems
(Minneapolis, MN). BD Compbeads compensation parti-
cle sets for optimising the flow cytometry fluorescence sig-
nals were purchased from BD Biosciences. Rabbit
polyclonal anti-SMAD 2/3 primary antibody was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
RNAse H was purchased from New England LaboratoriesRespiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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(Ipswich, MA). NucAway Spin columns and Taqman
Gene Expression Assays for α-smooth muscle actin and β-
2-microglobulin were purchased from Applied Biosys-
tems.
Animals
Mice bearing the PDGF-Rα-GFP allele were originally
obtained from Dr. Philippe Soriano (Fred Hutchinson
Cancer Center, Seattle, WA), and details regarding their
characterization and phenotype have been reported else-
where [30,31]. Briefly, the human histone H2B gene was
subcloned into a pEGFPN1 cloning vector to generate the
H2B-GFP construct encoding a nuclear form of GFP [32].
The resultant H2B-GFP construct was inserted into target-
ing (knock in) vectors. By homologous recombination in
the mouse embryos, these vectors replaced a fragment in
the wildtype pdgf-rα  allele corresponding to the signal
peptide and the first two immunoglobulin domains. Thus
nuclear GFP expression in the transgenic mice is under the
control of the endogenous pdgf-rα  promoter. Soriano's
group observed that GFP expression in the PDGF-Rα-GFP
mice recapitulated endogenous spatial and temporal
PDGF-Rα expression [30]. We used mice that were heter-
ozygous for the pdgf-rα-gfp allele; thus the mice still carry
one functional pdgf-rα allele. The heterozygous mice phe-
notypically resemble wildtype (GFP-) mice [30]. Mice
were housed in Thoren cages with access to food and
water ad libitum in a thermally regulated environment and
a 12-hour light/dark cycle. Protocols for animal use were
approved by the Iowa City Veterans Affairs Medical Center
animal use committee.
Isolation of mouse lung fibroblasts
Prior to the fibroblast isolation, mice were screened for
the PDGF-Rα-GFP allele using either PCR or fluorescence
microscopy. For PCR, 1 μl of tail DNA was mixed with
dNTPs, MgCl2, 10× PCR buffer, and the following GFP
primers: EGFP forward - 5' - GCC ATG CCC GAA GGC
TAC GTC - 3' EGFP reverse - 5' - GGG TGC TCA GGT AGT
GGT TGT C - 3' The amplification reaction was performed
in a thermocycler unit (Techne Limited, Cambridge UK).
To screen the animals using fluorescence microscopy, a
small piece of the lung was compressed on a glass slide
using a coverslip, and the presence or absence of GFP flu-
orescence was observed using an epifluorescence micro-
scope.
Primary mouse lung fibroblasts were isolated from 4 and
12-day old mice using a previously reported method, with
minor modifications [33]. After the animals had been
anesthetized with 25 μl of a mixture of 90 mg/ml keta-
mine and 10 mg/ml xylazine, their lungs were removed,
pooled together and digested for a total period of 1 h, with
removal of the dispersed cells every 10 minutes. The
enzyme solution consisted of Hanks buffered salt solution
(HBSS, without Ca or Mg) with 300 μg/ml collagenase
type I, 250 U trypsin (8500 U/mg solid), 75 μg/ml DNAse
I and 5 mM calcium chloride. After each digestion inter-
val, the solution containing dispersed cells was passed
through 100 μm mesh into Ham's F-12 k media contain-
ing 10% FBS, and the undigested lung tissue placed in
fresh enzyme solution. Once digestion was complete
(after 3-4 digestions), erythrocytes were separated from
the fibroblasts by sedimentation through a 40% Percoll
solution. To select for fibroblasts, cells were adhered to
100 mm tissue culture dishes for 1 h at 37°C. Adherent
cells were harvested by trypsinization followed by gentle
scraping and centrifugation.
Preparation of freshly isolated mouse lung fibroblasts for 
Flow Cytometry analysis of αSMA and Ki67
Freshly isolated mouse lung fibroblasts were propor-
tioned into aliquots of 5 × 105 cells and washed several
times by mixing with 1× phosphate-buffered saline (PBS -
0.145 M NaCl, 0.0015 M KH2PO4, 0.0027 M KCl, 0.0086
M Na2HPO4, pH 7.4) followed by centrifugation. Follow-
ing rinsing, the fibroblasts were fixed in 2% paraformalde-
hyde/PBS (v/v) for 20 min with shaking at 4°C. After
additional rinses in PBS, the fibroblasts were permeabi-
lized in 0.1% (w/v) saponin in PBS at 4°C for 10 min.
After the permeabilization step, non-specific binding was
reduced by incubating the fibroblasts in 5% non-fat dry
milk/0.1% saponin/PBS for 2 h at 4°C. Following the
blocking step, monoclonal rat anti-ki67 primary antibody
(1:300 dilution, clone TEC-3) or rat IgG2a was added to
the fibroblasts, and the cells incubated overnight at 4°C.
The next day, the cells were rinsed in 0.1% saponin/PBS.
In a sequential manner, Alexa Fluor 647-goat-anti rat sec-
ondary IgG (1 μg/ml) and phycoerythrin (PE) - anti-α-
smooth muscle actin primary antibody (0.0625 μg/ml) or
PE-mouse IgG2a were added and the cells incubated for 1
h at 4°C. Finally, the cells were rinsed in 0.1% saponin/
PBS, and resuspended in PBS for flow cytometry.
Collection and analysis of Flow Cytometry data
Flow cytometry was performed at the University of Iowa
Flow Cytometry facility using the LSR II instrument (BD
Bioscience). An unstained sample was used to gate the for-
ward and side scatter pattern of the cell population of
interest. Optimization of signal as well as compensation
for overlap between the PE and GFP or the Alexa Fluor
647 signals was achieved using BD Comp beads - polysty-
rene microparticles coated with mouse IgGκ or FBS (nega-
tive control, BD Bioscience) - stained in the same manner
as the fibroblasts. The resultant data were analyzed using
Cell Quest Pro (BD Biosciences), Microsoft Excel and
Sigma Stat software (Jandal Scientific, San Rafael, CA).
Each "n" represents a cohort of 2 to 5 mice, of the same
age, whose lungs had been pooled and digested together.
A minimum of 9000 gated events were analyzed for eachRespiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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"n." Background compensation was determined from the
IgG controls prior to calculating the proportions of the
different fibroblast populations.
Evaluating the purity of the fibroblast isolate
The fibroblast isolate was evaluated for epithelial,
endothelial and macrophage contamination using flow
cytometry. Epithelial cells were detected after fixation
using monoclonal mouse anti-cytokeratin 18 (Sigma),
followed by Alexa Fluor 647-conjugated goat anti-mouse
secondary IgG. Anti-cytokeratin independent staining was
assessed using only the secondary antibody. Endothelial
cells were stained prior to fixation using PE-conjugated
monoclonal rat anti-mouse CD31 or -mouse IgG1 isotype
control (BD Biosciences). Macrophages were detected
after fixation and permeabilization using Alexa Fluor 647-
conjugated-rat anti-mouse mannose receptor c type 1
(CD206) or -IgG2a (Serotec). Proportions of cells staining
positive for either cytokeratin 18, CD31 or CD206 were
determined after correcting for primary antibody-inde-
pendent fluorescence.
Preparation of Lung tissue for Confocal Microscopy 
studies
Confocal microscopy studies utilized either 100 or 7 μm
lung tissue sections obtained from mice at postnatal days
4 and 12. Preparation of the 100 μm sections has been
described elsewhere [20]. For the preparation of the 7 μm
sections, mice were anesthetized and their chests opened
to expose their lungs. The lungs were perfused transcar-
dially with 1× PBS and then inflated to total lung capacity
with a uniform quantity (for a particular age) of 75%
Optimal Cutting Temperature (OCT) Medium, dissected
out of the thoracic cavity, and frozen in a bath of liquid
nitrogen and isomethylbutane. The frozen lung tissue was
cut into 7 μm sections using a cryostat, mounted on glass
slides and stored at -20°C prior to fixation.
Immunofluorescence and Confocal Microscopy Imaging
The 100 μm sections were stained with Cy3-α-smooth
muscle actin monoclonal antibody (R & D systems, Min-
neapolis, MN) and a lipid counterstain, 1,1'-dioctadecyl-
3,3,3/,3/-tetramethylindodicarbo-cyanine perchlorate
(DiD, Invitrogen, Carlsbad, CA). The staining and imag-
ing processes have already been described in detail [20].
The 7 μm lung tissue sections were equilibrated at 4°C in
1× PBS for 5 min, and then fixed in 2% paraformaldehyde
for 1 h at 4°C. Fixed sections were then rinsed extensively
with 1× PBS. All subsequent antibody incubations were
performed in a humidified chamber, and rinses in Coplin
jars. Following the rinses, the lung tissue was permeabi-
lized in 0.1% Triton X-100/3 mg/ml bovine serum albu-
min (BSA) (permeabilization buffer) for 30 min at RT. To
minimize non-specific antibody binding, the tissue was
then placed in blocking solution - permeabilization
buffer/5% normal goat serum - overnight at 4°C. After the
blocking step, rabbit polyclonal anti-SMAD 2/3 primary
antibody (0.5 μg/ml) was added to the blocking solution,
and the incubation performed overnight at 4°C. The lung
tissue was subsequently rinsed with permeabilization
buffer, and then incubated with Alexa Fluor 647-goat anti-
rabbit secondary IgG (4 μg/ml) for 1.5 h at RT. After more
rinsing, the tissue was incubated for 40 min at 37°C with
1 × 10-7 M popo 3 iodide.
Images of the stained sections were acquired from ran-
domly selected fields using Zeiss LSM510 Laser Scanning
Confocal Microscopes (LSCM). The following excitation/
emission filters were used: a 488/505-530 nm band pass
filter to detect GFP fluorescence, a 533/560 nm long pass
filter to detect PoPo 3 iodide fluorescence, a 543/560-615
nm band pass filter to detect Cy3-α-smooth muscle actin
antibody, and a 650 nm long pass filter for detecting
either DiD or Alexa Fluor 647-goat anti-rabbit secondary
IgG. Z-stack images were obtained at 1024 × 1024 pixel
density.
Analysis of PDGF-Rα and αSMA in images acquired by 
laser scanning confocal microscopy
For analysis of images acquired from the 100 μm sections,
alveoli were identified and annotated in the 3 μm interval
z-stacks using StereoInvestigator (MBF Bioscience, Willis-
ton, VT). Each alveolus selected for analysis was traced
through the z-stack, and was defined as having an entry
ring and a base [20]. Inspection of the tissues revealed that
there were different levels of intensity of GFP-fluorescence
that were not related to the distance from the laser beam
or the detector. Therefore we devised uniform segmenta-
tion criteria using IP lab software (BD Bioscience, Rock-
ville, MD), which discriminated between populations of
nuclei with high and low intensities of GFP fluorescence.
Because the intensity of the GFP was intrinsic to the tissue
and not dependent on antibody staining, it is representa-
tive of the level of PDGF-Rα gene expression. To examine
PDGF-Rα-GFP distribution at the alveolar entry ring and
base, "low" and "high" PDGF-Rα-GFP cells were manu-
ally counted at each level.
The intensity of α-SMA staining was antibody-dependent,
thus we always imaged tissues obtained from P4 and P12
animals that were stained concurrently. To avoid variabil-
ity related to distances from the laser beam, alveolar entry
rings located 1/4 to 1/2 of the way into the z-stack were
used for analysis. To quantify the pixel density of αSMA
associated with PDGF-Rα expression at the alveolar entry
ring, a circle measuring 9 μm in diameter was drawn
around each PDGF-Rα-GFP nucleus. The pixel density of
αSMA was ascertained relative to this uniform region of
interest. The entry ring was defined by staining of αSMA,Respiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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which occupied at least 75% of the circumferential transi-
tion from an alveolar duct into an alveolus. The areal pixel
densities of αSMA were expressed in binned segments.
Analysis of nuclear SMAD 2/3 in the alveolar region
Localization of SMAD 2/3 to nuclei in cells that either
expressed PDGF-Rα (nuclei with GFP) or did not express
PDGF-Rα (nuclei without GFP) was ascertained as fol-
lows: The fluorescent DNA dye, PoPo3, was assigned a
blue pseudocolor. In the blue-only image, we optimized
the threshold intensity to accurately select pixels repre-
senting all blue nuclei (nuclei stained with PoPo3), and
quantified the pixel area covered by all the nuclei (all
nuclei comprised both those with and without GFP).
Next, in the green-only image, we selected only for the
nuclei, which also contained GFP above a fixed threshold
intensity, and quantified the total pixel area covered by
these nuclei. In order to ascertain the nuclear area occu-
pied by SMAD 2/3 (assigned the color red) but not GFP,
uniform segmentation criteria were applied to the red-
green-blue merged image, enabling selection of pixel seg-
ments which contained blue and red, but not green
(magenta). In order to ascertain the nuclear area occupied
by SMAD 2/3 and GFP, we applied uniform segmentation
criteria to the RGB merged image, enabling selection of
pixels which contained green and red (yellow). Finally, we
ascertained the proportional pixel areas of SMAD 2/3 in
nuclei that did or did not contain GFP using the following
formulas: (a) Fraction of SMAD 2/3 within GFP- nuclei =
area of magenta pixels ÷ (area of all nuclei minus area of
GFP+ nuclei) (b) Fraction of SMAD 2/3 within GFP+ nuclei
= area of yellow pixels ÷ area of GFP+ nuclei.
We applied this procedure to 3 different mice at P4 and at
P12, and examined all of the alveoli in at least 10 different
randomly selected fields per animal. The results were
expressed as mean ± SD, and ANOVA on ranks followed
by Dunn's posthoc test was used to determine statistical sig-
nificance.
Cell Culture
The neonatal mouse lung fibroblast cell line, MLg 2908
(CCL-206) was obtained from the American Type Culture
Collection (Manassas, VA). The cells were maintained at
5% CO2 and 37°C in T-75 flasks with MEM media con-
taining 10% FBS (v/v) and sub-cultured every 4 days. For
experiments, the cells were seeded into 100 mm tissue cul-
ture dishes. Cells were used between passages 3 and 10.
Assessing the effect of exogenous PDGF-AA and/or TGFβ 
treatment on αSMA mRNA expression in Mlg Cells
On day 1, the Mlg 2908 cells were plated in 10% FBS/
MEM media onto 100 mm tissue culture treated dishes at
a density of either 2 × 105(sub-confluent) or 2 × 106 (con-
fluent) cells. On day 2, the cell monolayer was rinsed with
Opti MEM I media, and 0.2% BSA/Opti MEM 1 media
was added. The concentrations of PDGF-AA and/or TGFβ
indicated in the figure legends were added 24 or 48 h after
serum starvation. Total RNA was isolated by the guanidin-
ium chloride method [34] 24 or 48 h post treatment.
Reverse Transcription of total RNA
Oligo (dT) primers and dNTPs were added to the total
RNA, and the RNA was denatured at 70°C for 15 min, and
then cooled on ice for 5 min. Subsequently, dithiothreitol
(DTT) and 5× first strand buffer were added to the sam-
ples, and they were annealed at 42°C for 5 min. To initiate
the reverse transcriptase reaction, Superscript II (Invitro-
gen) was then added, and the samples heated to 42°C for
50 min. The reaction was subsequently quenched by heat-
ing the samples to 70°C for 15 min. To remove any resid-
ual RNA, the samples were treated with RNAse H at 37°C
for 30 min. The cDNA product was diluted with TE buffer,
and placed on NucAway Spin Columns to remove salts
and unincorporated nucleotides. Concentrations of cDNA
were determined using the Quant IT™ Oligreen R ssDNA
Assay Kit.
Real-time quantitative PCR (RT-qPCR)
Quantification of αSMA mRNA was achieved by mixing 5
ng of cDNA with 1.5 μl of Taqman Gene Expression Assay
for  αSMA (probe number Mm01546133_m1) or β-2-
microglobulin (probe number Mm00437762_m1)
(housekeeping gene), and 15 μl of Taqman Universal PCR
MasterMix (catalogue number 4324018), to a final vol-
ume of 20 μl. The probes are designed to amplify exon-
intron junctions to minimize amplification of any
remaining genomic DNA. The Real-time PCR was per-
formed in triplicate (3 amplification reactions for one
reverse-transcribed RNA) using an Applied Biosystems
Model 7500 Sequence Detection System. At least four
independent experiments were performed. Values for the
αSMA expression were normalized to β-2-microglobulin,
and calculated in Excel using the 2(-ΔΔCT) relative quantifi-
cation method [35].
Statistics
Data were expressed as means ± SD. Unless otherwise
indicated, statistical significance was determined by per-
forming a 2-way Analysis of Variance followed by a Stu-
dent-Newman-Keuls post-hoc test. Values of p < 0.05 were
considered significant.
Results
The abundance of PDGF-Rα-expressing fibroblasts, which 
display varied PDGF-Rα levels, changes during alveolar 
development
In order to determine whether the size of the PDGF-Rα-
expressing fibroblast subpopulation changed according to
the stage of alveolarization, mouse lung fibroblasts wereRespiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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isolated from animals at 4 and 12 days of age (P4 and
P12). The purity of the fibroblasts was assessed by staining
for cellular markers specific for epithelial (cytokeratin 18),
macrophage (CD 206) and endothelial (CD31) cells. At
P4, epithelial, macrophage and endothelial comprised 2.7
± 3% (n = 4), 12.9 ± 3% (n = 3) and 1.0 ± 0.3% (n = 2,
mean ± SD) respectively, of the cells which adhered to cul-
ture plastic. At P12, epithelial, macrophage and endothe-
lial cells comprised 8.1 ± 6% (n = 2), 18.1 ± 1% (n = 3)
and 1.6 ± 0.5% (n = 3, mean ± SD) respectively, of the
adherent cells. At both ages, less than 6% of GFP positive
cells stained positive for any of these cellular markers.
Based on the relative intensities of GFP fluorescence as
measured on the X-axis of the flow cytometry histogram
(Figure 1B and 1C) we observed that the fibroblasts could
be distinguished as "low" and "high" PDGF-Rα-express-
ing groups. In addition, the "low" was distinctively sepa-
rable from the "high" population at postnatal day 4 (P4)
(1 B), but not at P12 (1 C). Furthermore, the overall pro-
portions of PDGF-Rα (GFP)-expressing fibroblasts were
lower at P12 compared to P4 (1 D, p < 0.05). These results
suggest that PDGF-Rα expression levels in the fibroblasts
change as alveolarization progresses.
There is a positive correlation between fibroblast PDGF-
Rα expression levels and proliferation at P4, but not P12
PDGF-A null mice lack myofibroblasts and secondary
alveolar septa, which is thought to result from a failure of
pdgf-rα-expressing mesenchymal cell precursors to
migrate from proximal tubules to the terminal primary
septae [13,14]. Because fibroblasts within the developing
secondary septae are known to actively proliferate during
septal formation, lack of alveolar septa could also result
from diminished PDGF-A-mediated fibroblast prolifera-
tion. In order to examine the correlation between PDGF-
Rα expression levels and the timing of fibroblast prolifer-
ation, we used flow cytometry to quantify the proportions
of Ki-67-containing, PDGF-Rα-GFP+ and PDGF-Rα-GFP-
fibroblasts at P4 (Figure 2D) and P12 (Figure 2H). In the
flow cytometry histograms, the "low" and "high" PDGF-
Rα subpopulations were distinct at P4 but not at P12
(compare Figure 2C and 2G). Therefore, we quantified
both populations at P4, but only the "high" group at P12.
Ki-67, which is only present when cells are actively prolif-
erating [36,37], increased concordantly with the level of
PDGF-Rα-GFP at P4 (Figure 2D, p < 0.05), but was
inversely correlated at P12 (Figure 2H, p < 0.05). These
data suggest that the varying PDGF-Rα expression levels
are functionally significant with regards to proliferation at
P4, as the proportion of proliferating fibroblasts within
the PDGF-Rα-GFP+ group increases with increasing recep-
tor expression levels. Conversely at P12, fewer of the
PDGF-Rα-GFP+ fibroblasts are proliferating, and may
mostly be in the G0 or G1 stages of the cell cycle.
There is a positive correlation between fibroblast αSMA 
expression and proliferation at P4, but not at P12
In order to define the correlation between the timing of
fibroblast differentiation and proliferation during alveo-
lar development, we compared proliferation of the αSMA-
expressing myofibroblasts at the beginning (P4) and the
middle (P12) of alveolar development. We analyzed the
same flow cytometric output that was shown in Figure 2.
The αSMA-containing myofibroblasts in this analysis rep-
resented a mixture of both PDGF-Rα-GFP+ and - popula-
tions. At P4, we observed that a greater proportion of
αSMA-expressing myofibroblasts contained ki67 com-
pared to the non-αSMA-expressing fibroblasts (Figure 3D,
p < 0.05). In contrast at P12, the converse was observed,
and a greater proportion of the fibroblasts that contained
ki67 lacked αSMA (Figure 3E, p < 0.05). Relative to the
The pattern of PDGF-Rα expression in mouse lung fibroblasts changes during alveolar development Figure 1
The pattern of PDGF-Rα expression in mouse lung fibroblasts changes during alveolar development. Mouse lung 
fibroblasts were isolated from either wildtype (WT, A) or mice carrying the PDGF-Rα-GFP transgene (GFP, B and C). Expres-
sion of PDGF-Rα-GFP was compared at postnatal days 4 (P4, B) and 12 (P12, C). The average abundance of GFP-positive 
fibroblasts expressed as a percentage of total fibroblasts (cells adherent to plastic after 1 h), is summarized in the column graph 
(D). For P4, n = 5 groups of 2 to 4 mice, and at P12, n = 7 groups of 2 to 4 mice. For the FACS histograms, "counts" on the y-
axis = the number of events, and on the x-axis, "GFP-A," = GFP Area. **, p < 0.001.
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αSMA non-expressing fibroblast population, our results
demonstrate that a greater proportion of the αSMA-con-
taining fibroblasts are proliferating at P4 than at P12.
Because a greater proportion of αSMA-containing myofi-
broblasts was within the PDGF-Rα-GFP+ group at both
ages, the data suggest that some of the proliferating myofi-
broblasts are PDGF-Rα-GFP+.
Proliferating fibroblasts at P4 are more likely to express 
PDGF-Rα but not αSMA, and at P12, neither PDGF-Rα nor 
αSMA
The previous analyses (Figures 2 and 3) enabled us to
examine age-related differences in the proportions of pro-
liferating fibroblasts within the populations defined by
either PDGF-Rα or αSMA expression as the primary varia-
ble. Using proliferation (Ki67) as the primary variable
within the same data set, we analyzed either αSMA or
PDGF-Rα as the secondary variable. Our results are sum-
marized in Figure 4. We observed that at P4, the prolifer-
ating fibroblasts were mostly PDGF-Rα-GFP+ but αSMA-
(Figure 4 A versus B, the left pair of columns, p < 0.05),
but at P12, the proliferating fibroblasts were mostly
PDGF-Rα-GFP- and αSMA- (Figure 4 A versus B, the right
pair of columns, p < 0.05). These data suggest that,
although some of the PDGF-Rα-expressing myofibrob-
lasts are proliferating at P4, the majority of the proliferat-
ing PDGF-Rα-expressing fibroblasts are undifferentiated
(lack αSMA). In contrast to P4, at P12 a majority of prolif-
erating fibroblasts express neither PDGF-Rα nor αSMA,
indicating a predominant proliferative effect of growth
factors other than PDGFs at P12 [38].
PDGF-Rα and αSMA expression levels positively correlate 
in developing alveolar tissues
Developmental studies using microscopy suggest that
PDGF-Rα-expressing cells in the interstitium of the pri-
mary septae could be αSMA-expressing myofibroblast
precursors [13,14]. However, the abundance of αSMA in
PDGF-Rα-expressing cells in the developing secondary
septa has not been studied. We hypothesized that if the
PDGF-Rα-expressing mesenchymal cells are indeed
myofibroblast precursors, then PDGF-Rα-expressing
fibroblasts should also contain αSMA. We observed that
freshly isolated total mouse lung fibroblasts expressing
PDGF-Rα expression positively correlates with proliferation at P4, but not at P12 Figure 2
PDGF-Rα expression positively correlates with proliferation at P4, but not at P12. Representative FACS histo-
grams of freshly isolated mouse lung fibroblasts from PDGF-Rα-GFP mice aged P4 (A - C) and P12 (E - G). Fibroblasts were 
stained for ki67 (C and G) or IgG control (B and F), followed by Alexa-Fluor 647-conjugated secondary antibody (A647, y-
axis). Negative controls stained with the secondary antibody only are shown in A and E. To analyze the flow cytometry output, 
cell populations were divided into regions; region 9 is R9, and so on. The proportions of non-expressing, or PDGF-Rα-GFP 
"low" or "high" subpopulations (shown by GFP fluorescence on the x-axis) that were positive or negative for ki67 were deter-
mined. Average percentages were summarized in column graphs for P4 (D) and P12 (H). At P12, only the "high" subpopulation 
was examined because the "low" subpopulation could not be accurately determined. Non-specific binding determined from the 
isotype-matched non-immune IgG control samples was removed from each experiment. Means are from n = 5 (groups of 2-4 
mice) for P4, and n = 7 for P12. Error bars represent SD; #, P < 0.05 and *, P < 0.001. For the FACS histograms, on the x-axis, 
"GFP-A" = GFP Area and on the y-axis, "A647-A" = A647 Area.
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the PDGF-Rα were more likely to contain αSMA than their
negative counterparts at both P4 and P12 (Figure 3F).
However, flow cytometry did not enable us to examine tis-
sue-colocalization of αSMA and PDGF-Rα-GFP.
Therefore we examined αSMA abundance (pixel area den-
sity) proximate to "low" or "high" PDGF-Rα-GFP nuclei.
In the PDGF-Rα-GFP mice a histone-nuclear localization
sequence restricts GFP expression to the nucleus [30,32].
Instead of the continuous variable histogram developed
by flow cytometric analysis, we used segmentation to
develop a discrete variable ("low" or "high") that identi-
fied separate pixel intensity ranges for either "low" or
"high" PDGF-Rα-GFP nuclei (Figure 5 arrow and arrow-
head in A). We evaluated co-localization of αSMA and
PDGF-Rα-GFP at the alveolar entry rings of different alve-
oli in tissue obtained from mice ages P4 and P12. A repre-
sentative set of images for a single alveolus taken at 3 μm
intervals through a confocal z stack is shown in Figure 5A-
E.
Using uniform segmentation criteria, pixels within a uni-
formly set range of Cy3 (αSMA) pixel intensities were
selected. We then quantified the area of segmented αSMA
pixels within a 4.5 μm radius around the center of each
"low" and "high" PDGF-Rα-GFP nucleus at the alveolar
entry ring. Our results are summarized in Figure 6. The fre-
quency histograms show the numbers of cells of the "low"
population at P4 (Figure 6A) and P12 (Figure 6D) and the
"high" population at P4 (Figure 6B) and P12 (Figure 6E)
associated with a particular αSMA pixel area binned range
of values. We found that at both P4 and at P12, larger
numbers of "high" than "low" PDGF-Rα-GFP nuclei were
associated with progressively higher ranges of αSMA pixel
The proliferative state of the myofibroblast (αSMA-expressing fibroblast) changes during alveolarization Figure 3
The proliferative state of the myofibroblast (αSMA-expressing fibroblast) changes during alveolarization. Rep-
resentative FACS histograms from freshly isolated mouse lung fibroblasts (A-C). Fibroblasts were stained with phycoerythrin 
(PE)-α-smooth muscle actin antibody (x-axis) plus anti-Ki67 followed by a secondary antibody conjugated to Alexa Fluor 647 
(A647, y-axis). Some samples were stained with only the A647 secondary antibody (A), non-immune IgG control for ki67 + 
secondary antibody and non-immune IgG control for α-smooth muscle actin (B), or with the anti-ki67 and anti-αSMA antibod-
ies (C). Proportions of fibroblasts that stained positively or negatively for either of the antibodies was determined, averaged 
and summarized in column graphs for P4 (D) and P12 (E). The fibroblast populations represent a mixture of PDGF-Rα-GFP-
positive and negative subpopulations. We determined that the majority of αSMA-containing fibroblasts expressed the PDGF-
Rα at both P4 and P12 (F). The shaded bars represent the αSMA-containing fibroblasts. Background compensation was deter-
mined from the non-immune IgG controls prior to calculating the proportions of the different fibroblast populations. For the 
mice ages P4, n = 5 groups of 2-4 mice, and for P12, n = 7 groups of 2-4 mice. #, P < 0.05 and *, P < 0.001. For the FACS his-
tograms, on the x-axis, "PE-A" = PE Area and on the y-axis, "A647-A" = A647 Area.
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area. In addition, we used the Kolmogorov-Smirnov non-
parametric test to evaluate whether there was a statistical
difference in the distribution of αSMA around the "low"
and "high" PDGF-Rα-GFP nuclei at each age (Figure 6C
and 6F, p < 0.05). The data suggest that the abundance of
αSMA expression is related to the level of PDGF-Rα gene
expression in adjacent alveolar cells.
The "low" and "high" PDGF-Ra-expressing fibroblasts are 
similarly distributed at the alveolar entry ring and base
We previously observed that a larger fraction of the alveo-
lar cells that expressed PDGF-Rα localized to the base at
P4 than at P12, but we did not distinguish cells based on
PDGF-Rα expression levels [20]. We reasoned that PDGF-
Rα expression levels could affect the responsiveness of the
fibroblast to PDGFs, thus the distribution of the "low"
and "high" populations at the ring versus the base could
reflect the contributions of each population to secondary
septal formation, and maintenance of alveolar structural
integrity. We examined the relative abundance of "low"
and "high" PDGF-Rα-expressing subpopulations at the
entry ring (Figure 5A) versus the base (Figure 5E). At both
the alveolar entry ring and base, "high" PDGF-Rα-express-
ing fibroblasts comprised a greater proportion of cells
compared to the "low" population, and this pattern did
not vary with age (Figure 7A and 7B). Thus there are no
anatomical or temporal differences in the distribution of
the "low" and "high" PDGF-Rα-expressing fibroblasts.
PDGF-A/PDGF-Rα signaling suppresses α-smooth muscle 
actin expression in a neonatal mouse lung fibroblast cell 
line
Deletion of the pdgfa gene resulted in a loss of α-SMA-
expressing myofibroblasts in the developing lung [13],
Relative contributions of PDGF-Rα- and αSMA- expressing and non-expressing fibroblasts within the ki67+ population Figure 4
Relative contributions of PDGF-Rα- and αSMA- expressing and non-expressing fibroblasts within the ki67+ 
population. Column graphs summarizing in the ki67+ fibroblasts at P4 and P12, (A) the proportions of PDGF-Rα-GFP+ and - 
groups and (B) the proportions of αSMA + and - groups. The same flow cytometry output from Figures 2 and 3 was used for 
this analysis. The shaded bars represent ki67+ groups and the clear bars represent ki67- groups. *, p < 0.001.
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Series of images representing a typical mature alveolus from a 12-day old PDGF-Rα-GFP mouse Figure 5
Series of images representing a typical mature alveolus from a 12-day old PDGF-Rα-GFP mouse. A representa-
tive 3 μm interval confocal z-stack of a single alveolus from the entry ring (A) to the base (E). The lung tissue was stained using 
Cy3-α-smooth muscle actin antibody (red) and the lipophilic carbocyanine dye, DiD (blue) for staining cell plasma membranes. 
The long white arrow shows a "high-expressing-PDGF-Rα " (high intensity of GFP) nucleus, and the white arrowhead shows a 
"low-expressing-PDGF-Rα-GFP" nucleus. The scale bar shown in (E) is 20 μm.
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Distribution patterns of αSMA around "low" and "high" PDGF-Ra-GFP nuclei in intact tissue Figure 6
Distribution patterns of αSMA around "low" and "high" PDGF-Ra-GFP nuclei in intact tissue. Frequency distribu-
tion histograms summarizing confocal image analysis of stained intact tissue from mice aged P4 (A - C) and P12 (D - F). A circle 
measuring 9 μm in diameter was drawn around each PDGF-Rα-GFP nucleus in an alveolar entry ring (Figure 5), and the pixel 
area of αSMA that fell within this region of interest was calculated. Statistical differences between the distribution of αSMA 
within the "low" and "high" populations at each age were calculated using the Kolmogorov-Smirnov (KS) test. KS-test compar-
ison percentile plots for P4 (C) and P12 (F) are shown. The αSMA pixel area values were ranked from lowest to highest, and 
the percentile for each value was determined (for example, the median value would be the 50th percentile, or 0.5). The cumu-
lative fractions were then plotted on the Y-axis, against the αSMA pixel areas on the X-axis. The αSMA distribution curves 
were statistically different (P < 0.05) between the "low" and "high" populations at each age. For each mouse, 16-18 alveolar 
entry rings were examined, and n = 3 mice at each age.Respiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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clearly demonstrating the importance of PDGF-A/PDGF-
Rα in myofibroblast ontogeny. However, it is still not
known whether the effect of PDGF-A on αSMA expression
is direct, or indirect. In an earlier study conducted by Dan-
dre and Owens [39] using primary cultured smooth mus-
cle cells, PDGF-BB suppressed αSMA only in sub-
confluent but not confluent cells.
To investigate the effects of PDGF-A on transdifferentia-
tion, we exposed a continuous line of neonatal mouse
lung fibroblasts (Mlg) to increasing doses of PDGF-AA for
24 h. PDGF-AA treatment resulted in suppression of
αSMA mRNA in sub-confluent cells (Figure 8A, p < 0.05),
suggesting that PDGF-A does not directly induce αSMA
expression. In a separate experiment, we compared the
effects of 20 ng/ml PDGF-AA on the steady state level of
αSMA mRNA in sub confluent versus confluent cells. As
shown in Figure 8B, the suppressive effects of PDGF-AA
on αSMA expression are dependent on cell density.
PDGF-AA/PDGF-Rα signaling represses the stimulatory 
effect of TGFβ on αSMA expression, and TGFβ releases 
αSMA from the PDGF-A-mediated suppressive effects
TGFβ is well characterized as a positive regulator of αSMA
expression in fibroblasts [22-24] and plays an important
role in postnatal lung development [25-27]. Since PDGF-
PDGF-Rα expression patterns are similar at the alveolar entry ring and base Figure 7
PDGF-Rα expression patterns are similar at the alveolar entry ring and base. The "low" and "high" PDGF-Rα sub-
populations were enumerated at the alveolar entry ring and base, and the results are summarized in the column graphs repre-
senting numbers for the P4 (A) and P12 (B) animals. Each subpopulation is expressed as a percentage of the total numbers of 
cells at each respective level (ring or base). N = 3 mice for each age. For each mouse, at least 45 alveoli were examined.
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PDGF-AA suppresses α-smooth muscle actin gene expression in sub-confluent mouse lung fibroblasts Figure 8
PDGF-AA suppresses α-smooth muscle actin gene expression in sub-confluent mouse lung fibroblasts. The neo-
natal mouse lung fibroblast cell line, Mlg, was stimulated with PDGF-AA (AA) for 24 h and levels of α-SMA mRNA for (A) 
increasing concentrations of PDGF-AA in sub-confluent cells (4.5 × 105 cells at the time AA was added), or (B) sub-confluent 
versus confluent cells (4.7 × 106 cells) was measured using real-time quantitative RT-PCR, with beta-2-microglobulin as the 
control "housekeeping" gene. For each reverse-transcribed RNA, 3 triplicate amplifications were performed. The error bars 
are 1 SD, columns are means of independent experiments. # = p < 0.05 compared to vehicle (veh).
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A had a repressive effect on αSMA in the subconfluent Mlg
cells (Figure 8), we investigated whether PDGF-A sup-
presses TGFβ-mediated  αSMA induction, and if TGFβ
releases  αSMA gene expression from the suppressive
effects of PDGF-AA. Our results are summarized in Figure
9. We observed that TGFβ treatment alone stimulated α-
SMA. However, addition of TGFβ followed by PDGF-AA
resulted in significantly lower levels of α-SMA expression
(p < 0.001). Conversely, addition of PDGF-AA alone
resulted in a repression of αSMA, and addition of PDGF-
AA followed by TGFβ resulted in a partial but significant
recovery of αSMA expression (p < 0.05). These data dem-
onstrate antagonistic interactions between intracellular
signaling pathways activated by TGFβ and PDGF-A.
PDGF-Rα expression does not preclude nuclear 
localization of SMAD 2/3 during alveolar development
Because our in vitro results suggested possible crosstalk
between intracellular signaling pathways activated by
PDGF-AA and TGFβ, we investigated TGFβ-dependent
SMAD 2/3 signaling in the PDGF-Rα-expressing fibrob-
lasts. At both postnatal days 4 and 12, we observed SMAD
2/3 nuclear localization in cells that were actively express-
ing the PDGF-Rα-GFP (Figure 10D). We then quantified
the pixel areas occupied by SMAD 2/3 within the nuclei of
either PDGF-Rα-expressing or non-expressing cells at
both ages (Figure 10E). At P4, the pixel area of SMAD 2/3
was similar in the nuclei of both the PDGF-Rα-expressing
and non-expressing cells. In contrast to P4, at P12 the
nuclear SMAD 2/3 was maintained in PDGF-Rα-express-
ing but diminished in the non-expressing cells. These data
suggest that PDGF-Rα gene expression does not preclude
TGFβ/SMAD intracellular signaling in the intact lung.
To verify that nuclear localization of SMAD 2/3 depended
on TGFβ-stimulation, we treated Mlg cells with either
vehicle or TGFβ, and stained the cells using the same
SMAD 2/3 antibody we used in the intact lung tissue.
Compared to vehicle, there was increased nuclear SMAD
2/3 staining with TGFβ treatment (Figure 10F).
Discussion
Although developmental studies [13,14] have clearly
demonstrated that PDGF-A is required to expand and
maintain alveolar myofibroblasts and septal outgrowth,
the timing and mechanisms of PDGF-A action have not
been defined. We have used GFP as a marker for endog-
enous PDGF-Rα gene expression to evaluate the prolifera-
tive and myofibroblastic characteristics of marked and
unmarked cells during alveolar septal eruption (P4) and
elongation (P12).
Our studies suggest that during septal eruption and elon-
gation, the proliferative characteristics of PDGF-Rα-
expressing fibroblasts vary with receptor expression levels.
Based on fluorescence intensity, we observed differential
PDGF-Rα expression in newly isolated fibroblasts using
flow cytometry (Figure 1) and in intact tissue using fluo-
rescence microscopy (Figure 5). This differential expres-
sion of the receptor is functionally significant, because
"low" expressing fibroblasts are less proliferative than the
"high" PDGF-Rα-expressing fibroblasts during septal
eruption at P4 (Figure 2), and there are larger pixel area
densities of αSMA protein proximate to the "high" than
"low" PDGF-Rα-GFP nuclei at both P4 and P12 (Figure
6).
"Low" expressing fibroblasts may be less sensitive to
PDGF-induced proliferation, either due to decreased
available surface receptor expression, and/or decreased
PDGF-AA dampens the stimulatory effect of TGFβ on α- smooth muscle actin mRNA expression Figure 9
PDGF-AA dampens the stimulatory effect of TGFβ 
on α-smooth muscle actin mRNA expression. As illus-
trated in the schematic (A), sub-confluent Mlg cells were 
stimulated with either vehicle (veh), PDGF-AA (AA) or 
TGFβ (T) at the different time points. The levels of α-SMA 
mRNA were determined for the different treatment groups 
after a total of 48 h, using quantitative real time RT-PCR, 
with beta-2-microglobulin as the "housekeeping" gene. For 
each reverse-transcribed RNA, 3 triplicate amplifications 
were performed. The column graph in (B) represents the 
average of 5 independent experiments. The error bars repre-
sent standard deviations from the averages for each treat-
ment group. *, P < 0.001 and #, P < 0.05.
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receptor activation. This hypothesis is consistent with pre-
vious reports of reductions in PDGF-A-mediated cell
growth associated with diminished PDGF-Rα expression
[40]. Hamilton et al [30] demonstrated using flow cytom-
etry that PDGF-Rα expression overlapped with GFP fluo-
rescence intensity in cells that had been derived from
PDGF-Rα-GFP mouse embryos. Our flow cytometry data
(Figure 1) also suggest that either the "low" population
decreases as alveolarization progresses, or may become
"high" PDGF-Rα-expressing. A proportional increase in
"high" PDGF-Rα-expressing fibroblasts may be advanta-
geous during septal elongation (P12) to support the for-
mation of a mature, elastin-laden ECM. Further studies
are required to determine whether "high" PDGF-Rα-
expressing fibroblasts produce more elastin.
Our data also suggests that the overall proliferative state of
the PDGF-Rα-expressing fibroblasts is different from the
non-expressing fibroblasts, and may depend on their dif-
ferentiative state. On postnatal day 4 (P4), at the onset of
septal eruption, a larger proportion of fibroblasts within
the PDGF-Rα- and αSMA- expressing groups were prolif-
erative compared to the proportions within the non-
expressing counterparts (Figures 2D and 3D). Conversely,
at P12 these proportions of proliferating fibroblasts
within the PDGF-Rα- and αSMA-expressing groups were
smaller compared to the non-expressing counterparts
(Figures 2H and 3E). A larger proportion of the PDGF-Rα-
GFP positive fibroblasts were αSMA-positive compared to
their PDGF-Rα-GFP negative counterparts at both P4 and
P12 (Figure 3F). Of the proliferating fibroblasts, PDGF-
Rα-expressing cells comprised a majority only at P4 and
αSMA-containing cells comprised a minority at both P4
and P12 (Figure 4). These results are consistent with a
transition of PDGF-Rα-expressing fibroblasts from a pro-
liferative to a less proliferative more differentiated, ECM-
producing state. A similar transition has been observed in
fibrotic states where myofibroblasts initially proliferate at
the site of injury, and thereafter become less proliferative
and produce more ECM proteins [41]. Our results corrob-
PDGF-Rα expression does not preclude SMAD-dependent TGFβ signaling in the lung Figure 10
PDGF-Rα expression does not preclude SMAD-dependent TGFβ signaling in the lung. Lung tissue from PDGF-Rα-
GFP mice aged P4 and P12 was stained for SMAD 2/3 followed by Alexa Fluor-568-conjugated secondary antibody (red, C) and 
PoPo 3 iodide nuclear counterstain (blue, A). The area of nuclear SMAD 2/3 was determined from merged images (D) in the 
nuclei cells that either express PDGF-Rα (yellow- red SMAD merged with green GFP) or do not express PDGF-Rα (magenta 
- red SMAD merged with blue pseudocolored PoPo3) cells. The inset in D (secondary antibody only) shows minimal levels of 
Alexa Fluor-568 staining in the absence of the primary antibody. Scale bars are 20 μm. Results are summarized in the column 
graph (E). The error bars represent standard deviations from the averages for each group. *, P < 0.001. To verify that nuclear 
translocation was TGFβ dependent, Mlg cells were treated with either vehicle or 0.125 ng/ml TGFβ (F) for 30 min and stained 
for SMAD 2/3 followed by 4', 6-diamidino-2-phenylindole (DAPI) nuclear counterstain. More SMAD 2/3 localized to the nuclei 
of TGFβ-treated cells.
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orate earlier electron micrographic studies showing that
the 3H-thymidine labelling indices of fibroblasts in the rat
and mouse lung was highest at P4, and afterwards
declined [42]. Our results suggest that during septal erup-
tion at P4, PDGF-Rα-expressing fibroblasts that are αSMA
expressing and non-expressing proliferate more, poten-
tially in response to PDGF-A. However, as alveolar septal
elongation progresses and septal eruption is abating by
P12, proliferation is less frequent among myofibroblasts
and among PDGF-Rα expressing cells.
Although pdgfa-null mice lack αSMA-expressing myofi-
broblasts, it is not clear whether PDGF-A can directly stim-
ulate αSMA expression in mouse lung fibroblasts. We thus
stimulated a neonatal mouse lung fibroblast cell line with
PDGF-AA and observed that PDGF-AA suppressed αSMA
mRNA expression only in sub-confluent, but had no effect
in confluent cells (Figure 8). These in vitro results do not
necessarily contradict our in vivo observations of greater
αSMA abundance around the "high" compared to the
"low" nuclei (Figure 6). Differences in αSMA distribution
around the "low" and "high" PDGF-Rα-expressing nuclei
may reflect cells undergoing heterogenous differentiation
pathways. PDGF-A/PDGF-Rα signalling during alveolar
development may not directly induce the myofibroblast
pathway, but instead regulate the numbers of fibroblasts
entering the transdifferentiation pathway. This theory is
consistent with earlier studies demonstrating that lung
fibroblasts can switch between the myo- and lipo- fibrob-
last phenotype, depending on the in vitro or in vivo pres-
ence or absence of (i) lipofibroblast-promoting
parathyroid hormone-related protein [43], or (ii) agonists
of the nuclear lipogenic transcription factor, peroxisome
proliferator-activated receptor gamma (PPARγ)[44,45].
Furthermore, studies in hepatic stellate cells (liver myofi-
broblasts) show that PDGFs inhibit lipofibroblast-pro-
moting pathways [46], and the formation of adipose
tissue [47]. It is possible that PDGF-A/PDGF-Rα signalling
could suppress lipid storage thereby indirectly enhancing
the myofibroblast phenotype during alveolar develop-
ment. This hypothesis is supported by earlier studies con-
ducted in our lab that showed a higher accumulation of
lipid droplets in the "low" compared to the "high" PDGF-
Rα-GFP nuclei [20].
Unlike PDGF-A, TGFβ promotes the myofibroblast phe-
notype in vivo and in vitro, and is also required for alveolar
development. Therefore we also investigated whether
PDGF-A and TGFβ have competing effects on αSMA
expression in Mlg cells. We observed that TGFβ increased
αSMA mRNA expression. However, subsequent addition
of PDGF-AA, or treatment with PDGF-AA alone, reduced
αSMA mRNA levels (Figure 9). Stimulation or repression
of αSMA gene expression is complex, and involves the
competitive binding of various positively- and negatively-
acting cell-specific transcription factor complexes to mul-
tiple elements within the αSMA promoter-enhancer
region, including the CC(AT-rich)6GG (CARG) and
AGGAATG (MCAT) sequences, as well as the TGFβ 1 con-
trol element (TCE) [48-52].
The suppressive effects of PDGF-AA on αSMA mRNA
expression are similar to observations made by Yoshida
and colleagues [52], who found that the PDGF-BB
repressed αSMA gene expression in smooth muscle cells
by inducing the dissociation of the positive-acting myo-
cardin related transcription factors (MRTFs or MKLs),
from the CArG elements. This dissociation resulted from
competitive binding between the PDGF-BB downstream
effector, Elk1, and the MRTFs at earlier than at later time-
points. PDGF-AA may act through similar mechanisms to
suppress TGFβ-mediated αSMA expression in fibroblasts,
because PDGF-A/PDGF-Rα signaling also activates down-
stream Elk-1 [53] and MRTFs are expressed in both embry-
onic and adult mouse lung tissue [54]. Furthermore, TGFβ
enhances the binding of positive-acting transcription fac-
tors such as serum response factor (SRF) to the CArG and
TCE elements in fibroblasts [50].
Whereas in cultured Mlg cells, PDGF-AA antagonized
TGFβ-mediated  αSMA expression (Figure 9), nuclear
SMAD 2/3 localization in PDGF-Rα-expressing cells was
preserved in the intact tissue during both septal eruption
(P4) and septal elongation (P12, Figure 10). However, in
the non-expressing cells, nuclear SMAD 2/3 was lower at
P12 compared to P4. Our results confirm earlier reports of
persistent SMAD 3 and phospho-SMAD 2 staining in the
developing alveolar interstitium until P28 [25]. To our
knowledge, our findings are the first to address differences
in SMAD 2/3 nuclear localization specifically in PDGF-
Rα-expressing and non-expressing cells within the alveo-
lar interstitium.
Our results also suggest that PDGF-Rα expression did not
preclude TGFβ/SMAD signaling at the indicated stages of
alveolar formation. We observed that a greater proportion
of PDGF-Rα-expressing fibroblasts at both P4 and P12
contained αSMA compared to their non-expressing coun-
terparts (Figure 3F). Therefore, other predominating fac-
tors may have maintained the myofibroblast phenotype,
and overridden any in vivo suppressive effects of PDGF/
PDGF-Rα signaling. Potential overriding factors include
the development of focal contacts between the myofi-
broblasts and ECM proteins [55,56], integrin-mediated
signaling via focal adhesion kinases [57], and increased
mechanical stretching related to septal formation and res-
piration [58,59]. An alternative explanation could be that
intracellular cross talk between PDGF-A and TGFβ signal-
ing may occur via SMAD-independent pathways. The
transcription factor known as early growth response-1Respiratory Research 2009, 10:119 http://respiratory-research.com/content/10/1/119
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(Egr-1), which is induced by both PDGF-B [60] and TGFβ
[61], is important for TGFβ-mediated collagen expression
in mouse lung fibroblasts. This Egr-1-dependent activity is
maintained even in fibroblasts derived from SMAD-3 null
mice [61]. Interestingly, tumor necrosis factor alpha
(TNFα) diminished TGFβ-mediated αSMA production in
primary cultured human neonatal lung fibroblasts, via
induction of Egr-1 without changing SMAD phosphoryla-
tion [62].
Conclusion
Our study has provided valuable information concerning
proliferative and differentiative characteristics of PDGF-
Rα-expressing fibroblasts during alveolar development.
We have demonstrated that PDGF-Rα expression levels in
vivo  positively correlate with αSMA protein expression
during both P4 and P12, and with proliferation at P4, but
not at P12. In addition, whereas the majority of prolifer-
ating fibroblasts at both stages are undifferentiated (non-
αSMA-expressing), most of the fibroblasts are PDGF-Rα +
at P4, but PDGF-Rα- at P12. In addition, we have demon-
strated that PDGF-AA suppresses TGFβ-mediated αSMA
induction in vitro, but PDGF-Rα expression does not pre-
clude TGFβ-dependent nuclear localization of SMAD 2/3
in vivo. Therefore the data support an indirect mechanism
for the PDGF-mediated regulation of the myofibroblast
(αSMA) phenotype, and also imply that fibroblasts
respond differently to PDGFs at different stages of alveo-
larization, possibly to regulate the timing of fibroblast dif-
ferentiation and function. Furthermore, PDGF-A/PDGF-
Rα signaling may separately or in combination with
TGFβ, regulate myofibroblast differentiation and function
during alveolar development. These interactions among
the intracellular pathways may be SMAD-independent,
and/or involve other myofibroblast-promoting factors
such as mechanical tension and cell-ECM interactions.
Our results and those of others demonstrate the complex
regulatory network that exists in the developing lung, and
how the myofibroblast plays a key role in driving the
process of alveolarization. Increasing understanding of
the delicate molecular balance that regulates myofibrob-
last differentiation and function could lead to improved
therapeutic strategies for fibrotic disease.
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